|Fero Industries Contracts PNP Pharmaceuticals |
Tuesday, 23 August 2011
Fero Industries Contracts PNP Pharmaceuticals for Exclusive Global Sucanon® Production
CALGARY, Canada, June 23, 2011 /PRNewswire via COMTEX News Network/ --
Fero Industries, Inc. (OTCQB: FROI) (the Company ) is pleased to announce that it has contracted PNP Pharmaceuticals Inc. as the exclusive global manufacturer of Sucanon®, an oral treatment for type-2 diabetes.
The addition of PNP Pharmaceuticals as the exclusive Sucanon® manufacturer will immediately allow us to expand our supply capabilities to meet current demands and satisfy the anticipated increase in product volume required as we expand Sucanon® into new territories around the globe, said Mr. Luis Lopez, Chief Operating Officer of Fero Industries. During this expansion period, maintaining absolute quality and formulation control is essential to our success. PNP's worldwide experience and dedication to excellence will ensure that we achieve these goals.
PNP Pharmaceuticals Inc. (PNP) is a leading Canadian contract manufacturer of pharmaceuticals, nutraceuticals, and other OTC products for export to markets worldwide. Founded in 1999, PNP has the expertise and high-volume production capabilities to formulate, blend, and package any form of Sucanon® (capsule, tablet, or bulk package for overseas transport) to the highest industry standards. PNP operates an ultra-modern 48,000 square foot manufacturing facility that meets or exceeds all Good Manufacturing Practice guidelines set forth by the US Food and Drug Administration (FDA) and World Health Organization (WHO). This facility was the first ever location in Canada to be issued a Natural Health Products Directorate (NHPD) site license. PNP is also Quality Management Systems certified ISO 9001:2000.
|New Building Under Construction |
Tuesday, 16 August 2011
PNP Pharmaceuticals Inc. Begins Construction on New 20 Million Dollar Production Facility
Construction has begun on PNP
Pharmaceuticals’ new 108,000 square foot facility located in the Glenlyon
Business Park, Burnaby, B.C. Completion
is scheduled for June 2012.
“Our new facility will allow us to continue
our growth in the pharmaceutical neutraceutical industry while expanding our
R&D and clinical division to help service our customer requirements.”
PNP Pharmaceuticals Inc.
President & CEO
|CHFA EAST 2009 |
Tuesday, 15 September 2009
PNP Pharmaceuticals Inc. will be exhibiting at CHFA East in Toronto, Ontario. Please visit us at booth #1736 located at the Metro Toronto Convention Centre.
|NSF Certification |
Tuesday, 15 September 2009
PNP Pharmaceuticals Inc. is proud to announce they have received registration by NSF International and have been found to be in compliance with Good Manufacturing Practices (GMP) as set forth in NSF/ANSI Standard 173-2008, Dietary Supplements, Section 8. These requirements are consistent with the published GMP regulation for dietary supplements as defined in 21 CFR § 111, which was published by the FDA in June
NSF International's Certified For Sport™
PNP Pharmaceuticals Inc. has received the highest sports certification in North America from the leading product safety and banned substances testing body for elite athletes. NSF’s special certification program is used by the Vancouver Organizing Committee for the 2010 Olympic and Paralympic Winter Games (VANOC), the Canadian Centre for Ethics in Sport (CCES), the National Football League (NFL), Major League Baseball (MLB), the Ladies Professional Golf Association (LPGA) and the PGA.
|New High Speed Packager |
Tuesday, 14 April 2009
PNP Pharmaceuticals Inc. is proud to announce the purchase of a high speed stick packer to package powdered material into single serving packs. PNP is the first Canadian company to offer high speed/volume stick packing service to both the nutraceutical and pharmaceutical markets.